| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TCR2 THERAPEUTICS INC. | Director | Stock Option (Right to Buy) | 0 | $0.7400 | 01 Jun 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000110465923067048-hoos-axel-2023-06-01 | TCR2 THERAPEUTICS INC. | 01 Jun 2023 | 4 | $0 | 4 | Director | 01 Jun 2023, 16:20 |
| /report/000089924322039015-hoos-axel-2022-12-15 | TCR2 THERAPEUTICS INC. | 15 Dec 2022 | 1 | $0 | 4 | Director | 19 Dec 2022, 16:16 |
| /report/000120919121069043-hoos-axel-2021-12-09 | TCR2 THERAPEUTICS INC. | 09 Dec 2021 | 1 | $0 | 4 | Director | 10 Dec 2021, 15:31 |